We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

31 hedge funds and large institutions have $2.63M invested in Perspective Therapeutics in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more capital invested

Capital invested by funds: $1.18M → $2.63M (+$1.45M)

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 30 → 31 (+1)

0.08% more ownership

Funds ownership: 0.55% → 0.62% (+0.08%)

Holders
31
Holders Change
+1
Holders Change %
+3.33%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$108K
2
BlackRock
BlackRock
New York
+$78.6K
3
HPWM
Highland Private Wealth Management
Washington
+$65.8K
4
CWM
Cahaba Wealth Management
Georgia
+$21.9K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$6.81K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$22.9K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$12K
3
Citadel Advisors
Citadel Advisors
Florida
-$11.9K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$6.23K
5
Millennium Management
Millennium Management
New York
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$996K -$6.23K -1,420 -0.9%
BlackRock
2
BlackRock
New York
$664K +$78.6K +17,919 +20%
HPWM
3
Highland Private Wealth Management
Washington
$175K +$65.8K +15,000 +115%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$170K +$1.27K +289 +1%
Renaissance Technologies
5
Renaissance Technologies
New York
$154K +$108K +24,655 New
Northern Trust
6
Northern Trust
Illinois
$73K -$1.15K -262 -2%
California Public Employees Retirement System
7
California Public Employees Retirement System
California
$73K – – –
CWM
8
Cahaba Wealth Management
Georgia
$65K +$21.9K +5,000 +91%
CAG
9
Crestwood Advisors Group
Massachusetts
$34K – – –
SIA
10
Starfire Investment Advisers
Michigan
$30K – – –
CPIG
11
Chicago Partners Investment Group
Illinois
$29K – – –
Citadel Advisors
12
Citadel Advisors
Florida
$23K -$11.9K -2,704 -42%
IFS
13
Ifrah Financial Services
Arkansas
$19K – – –
Commonwealth Equity Services
14
Commonwealth Equity Services
Massachusetts
$15K – – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$14K +$553 +126 +6%
RJFSA
16
Raymond James Financial Services Advisors
Florida
$12K +$658 +150 +9%
FIM
17
Frontier Investment Management
Texas
$11K – – –
HWM
18
HighMark Wealth Management
Minnesota
$11K +$7.89K +1,800 New
VF
19
Virtu Financial
New York
$10K -$22.9K -5,215 -77%
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
$10K +$6.81K +1,552 New
AAM
21
Auxier Asset Management
Oregon
$9K – – –
Truist Financial
22
Truist Financial
North Carolina
$8K +$5.88K +1,342 New
State Street
23
State Street
Massachusetts
$7K – – –
MC
24
Moors & Cabot
Massachusetts
$6K – – –
UBS Group
25
UBS Group
Switzerland
$4K +$241 +55 +8%
1
2

CATX Hedge Fund Activity: Q4 2019 in Review

31 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q4 2019, worth a combined $2.63M — up 123% from $1.18M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CATX positions and 5 closed out — a net gain of 1 holder — while 7 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $108K. The largest seller was Virtu Financial, cutting an estimated $22.9K.

  • 31 institutional investors held Perspective Therapeutics (CATX) as of Q4 2019, up from 30 in Q3 2019.
  • Funds reported $2.63M of Perspective Therapeutics stock for Q4 2019, up 123% quarter-over-quarter.
  • 6 funds opened new Perspective Therapeutics positions in Q4 2019 and 5 closed out, a net change of +1 holder.
  • The largest Perspective Therapeutics buyer in Q4 2019 was Renaissance Technologies, an estimated $108K added.
  • The largest Perspective Therapeutics seller in Q4 2019 was Virtu Financial, an estimated $22.9K sold.

Based on aggregated 13F filings for Q4 2019.